Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 12, keine Gesamtzahl für „section“
Suchtreffer
Begriffe & Kennungen
Beovu · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenBeromun · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenBeromun · 4.3 · Pregnancy and lactation (see section 4.6).
Eintrag öffnenBeromun · 4.5 · Concurrent administration of agents likely to cause significant hypotension is not recommended (see section 4.
Eintrag öffnenBesponsa · 4.3 · - Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. - Patients who h
Eintrag öffnenBesponsa · 4.5 · In patients receiving inotuzumab ozogamicin, prolonged QT interval was observed (see section 4.4). Therefore,
Eintrag öffnenBesponsa · 4.5 · No interaction studies have been performed (see section 5.2).
Eintrag öffnenBesponsa · 4.8 · 13 For clinical management of myelosuppression/cytopenias, see section 4.4.
Eintrag öffnenBesponsa · 4.8 · For clinical management of TLS, see section 4.4.
Eintrag öffnenBesponsa · 4.8 · For clinical management of bleeding/haemorrhagic events, see section 4.4.
Eintrag öffnenBesponsa · 4.8 · For clinical management of hepatotoxicity, including VOD/SOS, see section 4.4.
Eintrag öffnenBesponsa · 4.8 · For clinical management of infections, see section 4.4.
Eintrag öffnenBesponsa · 4.8 · For clinical management of infusion-related reactions, see section 4.4.
Eintrag öffnenBesponsa · 4.8 · For periodic monitoring of ECG and electrolyte levels, see section 4.4.
Eintrag öffnenBesponsa · 4.8 · For periodic monitoring of increased amylase and lipase, see section 4.4.
Eintrag öffnenBesremi · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 • Pre-existing th
Eintrag öffnenBetaferon · 4.8 · Renal and Urinary Nephrotic urinary urgency syndrome, disorders Glomerulosclerosis (see section 4.4)a, b Repro
Eintrag öffnenBetmiga · 4.3 · - Hypersensitivity to the active substance(s) or to any of the excipients listed in section 6.1. - Severe unco
Eintrag öffnenBetmiga · 4.3 · - Hypersensitivity to the active substance(s) or to any of the excipients listed in section 6.1. - Severe unco
Eintrag öffnenBexsero · 4.3 · Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Eintrag öffnen